Sources | Names Used |
---|---|
CTRPv2 | crizotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | crizotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | DENND5B | CTRPv2 | pan-cancer | AAC | -0.081 | 0.02 |
mRNA | RP11-159D12.5 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
mRNA | WDR82 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.02 |
mRNA | TFE3 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.02 |
mRNA | CNBP | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
mRNA | FCRL6 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.02 |
mRNA | RGS12 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.02 |
mRNA | GZF1 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.02 |
mRNA | RABGEF1 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.02 |
mRNA | MLX | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |